- Home
- HSCS vs PTHL Comparison
HSCS vs PTHL Comparison
Compare HSCS & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- PTHL
- Stock Information
- Founded
- HSCS 2007
- PTHL 1998
- Country
- HSCS United States
- PTHL China
- Employees
- HSCS N/A
- PTHL N/A
- Industry
- HSCS Medical Specialities
- PTHL
- Sector
- HSCS Health Care
- PTHL
- Exchange
- HSCS Nasdaq
- PTHL Nasdaq
- Market Cap
- HSCS 9.9M
- PTHL 10.0M
- IPO Year
- HSCS 2022
- PTHL 2024
- Fundamental
- Price
- HSCS $2.92
- PTHL $0.65
- Analyst Decision
- HSCS Strong Buy
- PTHL
- Analyst Count
- HSCS 2
- PTHL 0
- Target Price
- HSCS $10.50
- PTHL N/A
- AVG Volume (30 Days)
- HSCS 28.0K
- PTHL 100.8K
- Earning Date
- HSCS 12-15-2025
- PTHL 01-01-0001
- Dividend Yield
- HSCS N/A
- PTHL N/A
- EPS Growth
- HSCS N/A
- PTHL N/A
- EPS
- HSCS N/A
- PTHL N/A
- Revenue
- HSCS $6,250.00
- PTHL $448,196.00
- Revenue This Year
- HSCS N/A
- PTHL N/A
- Revenue Next Year
- HSCS N/A
- PTHL N/A
- P/E Ratio
- HSCS N/A
- PTHL N/A
- Revenue Growth
- HSCS N/A
- PTHL N/A
- 52 Week Low
- HSCS $2.52
- PTHL $0.51
- 52 Week High
- HSCS $6.47
- PTHL $32.00
- Technical
- Relative Strength Index (RSI)
- HSCS 30.44
- PTHL 37.67
- Support Level
- HSCS $3.16
- PTHL $0.58
- Resistance Level
- HSCS $3.43
- PTHL $0.67
- Average True Range (ATR)
- HSCS 0.14
- PTHL 0.06
- MACD
- HSCS -0.06
- PTHL 0.06
- Stochastic Oscillator
- HSCS 0.00
- PTHL 66.76
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.